These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 503307)

  • 1. Effect of benztropine on haloperidol-induced prolactin secretion.
    Lal S; Mendis T; Cervantes P; Guyda H; DeRivera JL
    Neuropsychobiology; 1979; 5(6):327-31. PubMed ID: 503307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of benztropine on the diurnal prolactin responses to haloperidol.
    Nathan RS; Perel JM; McCarthy T; Jarrett DB
    Psychoneuroendocrinology; 1985; 10(1):71-6. PubMed ID: 3889966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benztropine mesylate on haloperidol-induced prolactin secretion and serum haloperidol levels in rats.
    Rosenberg JM; Sideman M; Kampa IS; McGuire H; Kampa L
    J Pharm Sci; 1984 Dec; 73(12):1833-5. PubMed ID: 6527272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of benztropine mesylate on the prolactin response to haloperidol.
    Halbreich U; Sachar EJ; Nathan RS; Asnis GM; Halpern FS
    Psychopharmacology (Berl); 1980; 72(1):61-5. PubMed ID: 6781007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic benztropine and haloperidol administration induce behaviorally equivalent pharmacological hypersensitivities separately but not in combination.
    Carey RJ; De Veaugh-Geiss J
    Psychopharmacology (Berl); 1982; 76(4):341-5. PubMed ID: 6812108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of atropine, benztropine and diphenhydramine on the reversal of haloperidol induced suppression of self-stimulation.
    Carey RJ
    Pharmacol Biochem Behav; 1982 Oct; 17(4):851-4. PubMed ID: 7178193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of haloperidol induced deficits in self-stimulation by anti-Parkinsonian drugs.
    Carey RJ
    Behav Brain Res; 1983 Dec; 10(2-3):405-11. PubMed ID: 6318780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal development of benztropine-induced locomotor stimulation: evidence for an anticholinergic mechanism of action.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):313-20. PubMed ID: 4734004
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    Bowden CR; Voina SJ; Woestenborghs R; De Coster R; Heykants J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):699-706. PubMed ID: 1380082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benztropine-induced prolongation of responses to vasodilator nerve stimulation in the canine paw pad.
    Bell C
    Br J Pharmacol; 1982 Jun; 76(2):231-3. PubMed ID: 7093584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion.
    Veselinović T; Schorn H; Vernaleken IB; Schiffl K; Klomp M; Gründer G
    J Clin Psychopharmacol; 2011 Apr; 31(2):214-20. PubMed ID: 21346608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic psychosis in a patient receiving usual doses of haloperidol, desipramine, and benztropine.
    Hvizdos AJ; Bennett JA; Wells BG; Rappaport KB; Mendel SA
    Clin Pharm; 1983; 2(2):174-8. PubMed ID: 6883947
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of benzatropine on the O-methylation of striatal dopamine].
    Bidard JN; Cronenberger L
    C R Acad Hebd Seances Acad Sci D; 1977 Feb; 284(6):485-7. PubMed ID: 404079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoactive properties of benztropine and trihexyphenidyl.
    Wilcox JA
    J Psychoactive Drugs; 1983; 15(4):319-21. PubMed ID: 6655530
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
    Meltzer HY; Fessler RG; Fang VS
    Psychopharmacology (Berl); 1977 Oct; 54(2):183-6. PubMed ID: 412213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.